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Abstract
Background: Tissue-specific stem/progenitor cells are found in various adult tissues and may have the capacity
for lineage-specific differentiation, facilitating applications in autologous transplantation. Stage-specific embryonic
antigen 4 (SSEA-4), an early embryonic glycolipid antigen, is expressed in cells derived from adult human pancreas
exocrine tissue. Here, we examined the characteristics and lineage-specific differentiation capacity of SSEA-4+ cells.
Methods: Human adult partial pancreas tissues were obtained from different donors and cultured in vitro. SSEA-4+
and CA19-9+ cells were isolated from adult human pancreas exocrine cells using magnetic-activated cell sorting,
and gene expression was validated by quantitative polymerase chain reaction. To confirm in-vivo differentiation,
SSEA-4+ and CA19-9+ cells were transplanted into the dorsal subcutaneous region of mice. Finally, morphological
features of differentiated areas were confirmed by immunostaining and morphometric analysis.
Results: SSEA-4-expressing cells were detected in isolated pancreas exocrine cells from adult humans. These SSEA-4+
cells exhibited coexpression of CA19-9, a marker of pancreatic duct cells, but not amylase expression, as shown by
immunostaining and flow cytometry. SSEA-4+ cells exhibited higher relative expression of Oct4, Nanog, Klf4, Sox2, and
c-Myc mRNAs than CA19-9+ cells. Pancreatic intralobular ducts (PIDs) were generated from SSEA-4+ or CA19-9+ cells in
vivo at 5 weeks after transplantation. However, newly formed PIDs from CA19-9+ cells were less abundant and showed
an incomplete PID morphology. In contrast, newly formed PIDs from SSEA-4+ cells were abundant in the transplanted
area and showed a crowded morphology, typical of PIDs. Sox9 and Ngn3, key transcription factors associated with
pancreatic development and regeneration, were expressed in PIDs from SSEA-4+ cells.
Conclusions: SSEA-4-expressing cells in the adult human pancreas may have the potential for regeneration of the
pancreas and may be used as a source of stem/progenitor cells for pancreatic cell lineage-specific differentiation.
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Background
Embryonic stem (ES) cells are undifferentiated cells
derived from 5-day preimplantation embryos and are
capable of self-renewal, exhibiting pluripotency for the
three primary germ layers (ectoderm, endoderm, and
mesoderm) [1, 2]. Thus, ES cells are present and have
the capacity to differentiate into any cell type only in the
embryonic development stage. Cells will then gradually
develop into adult cells, and the number of ES/progeni-
tor cells is rapidly reduced, along with a decrease in
potential differentiation activity. However, previous stud-
ies have suggested that embryonic-like stem cells, also
called very small embryonic-like stem cells (VSELs), are
present in various adult tissues, such as mammalian
ovaries [3, 4], blood [5, 6], and umbilical cord blood
[7, 8]. Additionally, some cells expressing ES cell-
specific markers, such as Oct4, Nanog, and stage-specific
embryonic antigen 4 (SSEA-4), have been identified in
cord blood [9] and the adult pancreas [10]. Interestingly,
the ES-like cells identified in adult tissue do not have all
of the characteristic features of ES cells but still have the
ability to differentiate into specific cells. Therefore, many
researchers have studied the applications of ES-like cells
isolated from adult tissues in regenerative therapies for a
variety of diseases [11–14].
The adult pancreas is functionally divided into
exocrine and endocrine cells, and the two glands are in-
timately mixed together into one single organ. Endocrine
cells—called islets of Langerhans—release hormones,
such as insulin and glucagon, into the bloodstream;
these hormones in turn help to control blood glucose
levels. Dysfunction of beta cells, which secrete insulin, is
directly related to diabetes [15]. Therefore, many re-
searchers have studied beta cell recovery using stem cell
therapy. In the adult human pancreas, Afrikanova et al.
[10] found that cells positive for SSEA-4, an early em-
bryonic glycolipid antigen, and duct marker proteins
could differentiate into pancreatic hormone-expressing
cells. They hypothesized that SSEA-4-positive cells may
function as human pancreatic stem/progenitors. Unlike
other markers of stem cells, such as transcription fac-
tors, SSEA-4 is expressed on the surface of ES cells, and
it is possible to isolate these cells from tissues using an
antigen-antibody reaction-based method without dam-
aging the cells.
In this study, we examined whether isolated SSEA-4-
expressing cells from adult human pancreas exocrine
cells could differentiate to pancreatic ducts in vivo. We
hypothesized that ES cells may remain quiescent for a
long period in adult human pancreatic tissue after the
end of embryonic development stage and that cells hav-
ing specific features of embryonic-like stem cells in adult
human pancreatic tissue could persist. Therefore, we
expected that SSEA-4-expressing cells derived from the
human adult pancreas might have the ability to differen-
tiate into pancreatic lineage cells, including pancreatic
duct cells, as observed in the early stages of pancreas
development.
Methods
Human pancreas exocrine cell isolation and culture
Five human adult partial pancreas tissues were obtained
from different donors in compliance with the provisions
of the Institutional Review Board (IRB) of the Asan
Medical Center, Seoul, Korea and in accordance with the
Declaration of Helsinki and Good Clinical Practices. To
obtain pure exocrine cells, we preferentially removed
the islets from the adult pancreas using the modified
Ricordi method of pancreas islet isolation [16]. Briefly,
collagenase-digested pancreatic tissues were subjected
to a continuous-density gradient with Optiprep solution
(Sigma-Aldrich, St. Louis, MO, USA) using a COBE 2991
cell processor (Gambro BCT, Inc., Lakewood, CO, USA).
Exocrine cells were cultured in adherent in Dulbecco’s
modified Eagle medium (DMEM; Gibco, Carlsbad, CA,
USA) supplemented with 10 % fetal bovine serum (FBS)
and 1 % antibiotics or in suspension in KnockOut DMEM
supplemented with 15 % KnockOut serum replacement
and 1 % antibiotics in tissue culture plates at 37 °C and
5 % CO2. Adherent culture medium and suspension
medium were changed at 12 h after the first seeding
and then changed every day for 2 days in order to elimin-
ate dying exocrine cells.
Immunofluorescence staining
For immunocytochemistry, human exocrine cells were
cultured on coverslips in 24-well culture plates and fixed
with 4 % paraformaldehyde (PFA; Merck, Darmstadt,
Germany) for 30 min at 4 °C, followed by washing three
times with phosphate-buffered saline (PBS). For detec-
tion of cytoplasm markers such as insulin, glucagon, and
amylase, cells were permeabilized with 0.3 % Triton
X-100 at 4 °C for 5 min and washed three times with
PBS. For markers that are expressed in the nucleus,
such as Sox9, neurogenin3 (Ngn3), Pdx1, and Ki67,
paraffin-embedded slide sections were subjected to
antigen retrieval by boiling for 5 min with 10 mM so-
dium citrate buffer (pH 6.0) and then cooled slowly
at room temperature. To block nonspecific binding of
the antibody, cell or paraffin slide sections were incu-
bated in 5 % normal goat or normal horse serum for
30 min at room temperature. The primary antibody
was incubated with anti-rabbit insulin (1:200; Santa
Cruz Biotechnology, Santa Cruz, CA, USA), rabbit
anti-human glucagon (1:100; DaKo, Glostrup, Denmark),
anti-rabbit amylase (1:200; Sigma-Aldrich), anti-mouse
CA19-9 (1:200; Leica Biosystems), and anti-mouse cyto-
keratin19 (Ck19; 1:200; Santa Cruz Biotechnology) in
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order to identify endocrine and exocrine cells. Anti-mouse
SSEA4 (1:150; Abcam, Cambridge, UK) was used as a
marker of embryonic-like stem cells. For detection of
pancreatic transcription factors, we used anti-rabbit Sox9
(1:200; Millipore, Temecula, CA, USA), anti-rabbit Ngn3
(1:200; Abcam), and anti-goat Pdx1 (1:10000; Abcam).
Proliferation of cells was determined using anti-mouse
Ki67 (1:100; Millipore), and differentiation was assessed
using anti-goat clusterin (1:200; Santa Cruz Biotechnol-
ogy). All primary antibodies were incubated overnight at
4 °C. For secondary fluorescence labeling, cells or tissues
were incubated with Alexa Fluor 488 goat anti-mouse or
anti-rabbit IgG (1:200; Life Technologies, Carlsbad, CA,
USA) and Alexa Fluor 594 goat anti-rabbit IgG (1:200; Life
Technologies). Hoechst 33342 (1:100; Thermo Scientific,
Rockford, IL, USA) or 4′,6-diamidino-2-phenylindole
(DAPI, 1:150; Life Technologies) was used to stain nuclei
for 3 min at room temperature, and cells were then
washed three times with PBS. The slides were visualized
under an LSM710 confocal microscope (Carl Zeiss,
Oberkochen, Germany).
Flow cytometry
Adhesion or suspension cultures of exocrine cells were
separated with 0.05 % trypsin–EDTA (Gibco) and fixated
with 4 % PFA. SSEA-4, CA19-9, and amylase antibodies
were conjugated with anti-mouse IgG phycoerythrin
(PE) or Alexa Fluor 488 anti-mouse or anti-rabbit IgG
(Life Technologies) at RT for 1 h. The exocrine single
cells were incubated with PE-conjugated monoclonal
anti-SSEA4, Alexa Fluor 488-conjugated anti-CA19-9, or
Alexa Fluor 488-conjugated anti-amylase at 4 °C for 30
min in the dark. After washing twice, labeled cells were
analyzed on a FACS Caliber flow cytometer (BD
Biosciences).
Cell sorting
The sphere forms of exocrine cells in suspension cul-
ture were separated into single cells by treatment
with 0.25 % trypsin–EDTA solution (Gibco). After
washing twice with PBS, single cells were filtered with
a 70-μm nylon cell strainer (Falcon, Corning, NY,
USA). For specific sorting of SSEA-4+ or CA19-9+
cells, 2 × 108 cells were incubated with anti-mouse
SSEA-4 (1:150; Abcam) or anti-mouse CA19-9 (1:200;
Leica Biosystems) for 30 min at room temperature
and then washed twice with PBS. Subsequently, the
cells are magnetically labeled with anti-mouse IgG
microbeads (Miltenyl Biotec, Auburn, CA, USA). The
cell suspensions were then loaded onto a magnetic-
activated cell sorting (MACS) column. The magnetic-
ally labeled SSEA-4+ or CA19-9+ cells were isolated
by elution with PBS after removing the column from
the magnetic field. SSEA-4– or CA19-9– cells were
obtained from each nonbinding negative fraction.
Reverse-transcription polymerase chain reaction
Total RNA was extracted from crude exocrine cells on
culture days 2, 4, 6, and 8 or pure fractions of separated
cells after MACS sorting using TRIzol (Invitrogen) ac-
cording to the manufacturer’s instructions. cDNA was
synthesized from 0.5–1 μg RNA template using oligo-dT
primers with a SuperScript III reverse transcription kit
(Invitrogen) at 50 °C for 60 min and 70 °C for 15 min.
Polymerase chain reaction (PCR) was performed using
rTaq Plus Master Mix (ELPIS Biotech, Seoul, South
Korea) with gene-specific forward and reverse primers
(Additional file 1: Table S1a). PCR amplification condi-
tions were as follows: initial denaturation at 95 °C for 5
min, followed by 30 cycles at 95 °C for 20 s, 55 °C or 57
°C for 20 s, and extension at 72 °C for 20 s, with a final
extension at 72 °C for 3 min. Reverse-transcription-PCR
results were normalized against the β-actin housekeep-
ing gene.
Quantitative PCR
Quantitative PCR (qPCR) products were monitored with
a TaqMan probe using AccuPower Plus DualStar qPCR
premix (Bioneer, Daejeon, Korea). The TaqMan assays
used the 5′ to 3′ exonuclease activity of Taq DNA poly-
merase, and each reaction contained a gene-specific pri-
mer and a fluorescent dye-labeled TaqMan probe. The
probe contained the 5′-reporter dye FAM (6-carboxyflu-
orescein) and the 3′-quencher dye TAMRA (carboxyte-
tramethylrhodamine), and each probe was designed to
anneal to the target sequence between the forward and
reverse PCR primers. Human ES cells expressing gene-
specific primers were also designed (Additional file 1:
Table S1b). The qPCR program included a three-step re-
action, with predenaturation at 95 °C for 5 min followed
by 40 cycles of denaturation at 95 °C for 15 s, annealing
at 55 °C or 57 °C for 15 s, and extension/detection at 72
°C for 15 s. After the reaction was completed, gene
expression analyses using the 2−(△△Ct) method were per-
formed in order to calculate relative expression.
In-vivo transplantation
We used 8-week-old male BALB/c nude mice (n = 3;
Orient Bio Inc., Gyeonggi, Korea) for cell transplant-
ation. All procedures, including the experimental animal
treatment and surgical procedures, were approved by
the Institutional Animal Care and Use Committee of
Asan Medical Center (AMC). Anesthesia was achieved
by inhalation of gaseous nitrous oxide–oxygen and
isoflurane. SSEA-4-positive, SSEA-4-negative, CA19-9-
positive, or CA19-9-negative cells (1 × 107 total cells)
were inoculated with Matrigel subcutaneously into the
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dorsal region in each mouse. After 5 weeks, mice were
sacrificed, and transplanted cells were collected, fixed
with 4 % PFA, and embedded in paraffin.
Morphometric analysis
Each of the separated cell populations was transplanted
with Matrigel into the dorsal subcutaneous region of the
mice, allowing easy sampling. The paraffin-embedded
transplanted cells were sectioned to 5-μm thickness and
stained with hematoxylin and eosin (H&E). Three to five
serial sections were examined for each specimen. To
measure the area of newly formed pancreatic ducts on
H&E-stained slides, the tissues were photographed with
lower magnification (10×) to integrate whole-tissue
images using Photoshop (Microsoft Co., San Jose, CA,
USA). We delineated the outermost newly formed pan-
creatic ducts to determine the area of each regenerating
lobule relative to the total transplant area. The dimen-
sions of each newly formed pancreatic duct and whole
tissues on slides were defined as the total transplanted
area and measured area total transplantation using
ImageJ (1.47v; Wayne Rasband, NIH, USA).
To measure of numbers of Sox9-positive or Ngn3-
positive cells in newly formed pancreatic ducts, nuclear
staining was performed with a FITC fluorescent dye and
quantified using Image Pro Plus (5.1.0.20v; Media Cyber-
netics, Inc., Rockville, MD, USA). The number of posi-
tively stained cells was determined relative to the total
number of pancreatic ductal cells stained with DAPI.
Data from three different animals in each group were
used for statistical analysis. For standard calculations,
the area sizes (mm2) and cell counting numbers were
converted into percentages (%).
Statistical analysis
Continuous normally distributed variables are summa-
rized and presented as the mean ± standard deviation
(SD). qPCR data were presented as the mean value,
determined using duplicates. To calculate the relative
expression, the expression of the control was fixed at 1.
Statistical analysis was performed using SigmaPlot 8.0
statistical software (SPSS Inc., Chicago, IL, USA), and
two-sided Student’s t tests were used. Differences with
p < 0.05 were considered significant.
Results
SSEA-4-expressing cells in adult human exocrine pancreas
cells
The isolated crude exocrine cells from the adult hu-
man pancreas attached properly and proliferated rap-
idly on tissue culture plates. The morphologies of
cultured exocrine cells resembled typical epithelial-like
cells (Fig. 1a). These cured exocrine cells mostly consisted
of pancreatic duct cells and acinar cells, confirmed by
immunocytochemistry with anti-Ck19, a marker of pan-
creatic duct cells (Fig. 1d), or anti-amylase, a typical di-
gestive juice enzyme secreted by acinar cells (Fig. 1g).
However, insulin (Fig. 1b) and glucagon (Fig. 1c) were not
found. SSEA-4, a specific marker of ES cells, was also de-
tected in the crude exocrine cells (Fig. 1e, h). In addition,
few SSEA-4-expressing cells exhibited coexpression of
CA19-9 (Fig. 1f) or amylase (Fig. 1i). We conducted FACS
analysis in order to confirm the quantitative distribution
of SSEA-4+ cells in adult human exocrine cells. In adult
human exocrine cells culture, CA19-9+ cells were detected
in substantial amounts (68.21 ± 6.57 %; Fig. 2a) and
amylase-positive cells were detected in moderate amounts
(12.22 ± 5.18 %; Fig. 2b). To identify SSEA-4-expressing
cells, we analyzed separated cell populations according to
cell size (common cell size: 50,000–150,000 FSC; small cell
size: 10,000–50,000 FSC; Fig. 2c); this allowed us to con-
firm whether SSEA-4+ cells in adult human exocrine cells
belonged to the subtype of VSEL cells, which are known
to be present in adult tissues. Expression levels of SSEA-4
+ cells were similar in cells with a common cell size
(21.57 ± 3.17 %; Fig. 2e, Q1) and cells with a small cell size
(12.44 ± 3.45 %; Fig. 2i, Q1-1). Cells coexpressing SSEA-4
and CA19-9 were found in 9.65 ± 2.68 % of cells with a
common cell size (Fig. 2f, Q2) and in 7.72 ± 0.86 % of cells
with a small cell size (Fig. 2j, Q2-1). In addition, coexpres-
sion of amylase and SSEA-4 was observed in only 1.07 ±
0.58 % of cells with a common cell size (Fig. 2g, Q2) and
in 0.67 ± 0.36 % of cells with a small cell size (Fig. 2k, Q2-
1). Based on these results, cells expressing SSEA-4 were
relatively rare in adult human exocrine pancreas cells and
could not be distinguished based on cell size. Moreover,
most SSEA-4+ cells were present in pancreatic duct cells.
Characterization of pure isolated SSEA-4+ cells from the
adult human exocrine pancreas
Pancreas progenitor cells that can be differentiated into
endocrine cells, including insulin-producing cells, were
identified in pancreatic duct cells. However, not all pan-
creatic duct cells are progenitor cells, and many other
factors determine the fate of pancreatic progenitor cells.
We hypothesized that SSEA-4 may be used as a marker
of adult human pancreatic progenitor cells and that
SSEA-4+ cells may have the capacity for differentiation.
Therefore, we analyzed purified SSEA4+, SSEA4–, CA19-
9+, and CA19-9– cells from the adult human exocrine
pancreas.
In the initial culture of exocrine cells, we evaluated ad-
herent cultures; however, a substantial number of cells
could not reattach to the plates during passaging. There-
fore, exocrine cells were cultured in suspensions imme-
diately after isolation from the adult human pancreas in
order to allow for continuous culture. In 3-day suspen-
sion cultures, exocrine cells aggregated and formed
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spheres (Fig. 3a, b). CA19-9-expressing pancreatic duct
cells (Fig. 3c) and SSEA-4-expressing cells (Fig. 3d) were
detected consistently; however, insulin-expressing cells
were not detected (Fig. 3e) in sphere exocrine cells. Sep-
arate preparations of pure pancreatic duct cells and
SSEA-4+ cells were collected using MACS with anti-
CA19-9 or anti-SSEA-4 antibodies, respectively (Fig. 3a).
In pure cell culture after separation, we confirmed
that SSEA-4 was expressed only in SSEA-4+ cells and
not in SSEA-4– cells (Fig. 3f ), whereas CA19-9 was
expressed only in CA19-9+ cells (Fig. 3g), as deter-
mined by immunocytochemistry. The purified cells,
however, exhibited decreased cell viability for both
SSEA-4+ and CA19-9+ cells during culture for 6 days
(Fig. 3h). Based on these results, isolated pure single
cells appeared to have features of primary cells and
were therefore not able to grow when cultured as sin-
gle cells in vitro.
We then extracted RNA from separated pure single-
cell suspensions for further characterization of the ES
cells. In crude exocrine cells before separation, ES cell-
specific markers, such as Oct4, Nanog, Klf4, and c-Myc,
were found to be expressed in all cultures during the
first 8 days of culture; however, Sox2 was not detected
by conventional PCR (Fig. 4a). We compared the relative
expression levels of ES cell markers between each of the
separated cell fractions (CA19-9+/– and SSEA-4+/–) by
qPCR. CA19-9+ cells showed high relative expression
levels of Oct4 and Klf4, but low expression of Nanog,
Sox2, and c-Myc compared with CA19-9– cells (Fig. 4b).
However, the relative expression levels of Oct4, Nanog,
Klf4, and Sox2 were higher in SSEA-4+ cells than in
SSEA-4– cells (Fig. 4c). In particular, SSEA-4+ cells
showed high relative expression levels of Oct4, Nanog,
Klf4, Sox2, and c-Myc compared with CA19-9+ cells
(Fig. 4d). These results showed that although the SSEA-4+
Fig. 1 SSEA-4 expression in adult human exocrine cells. a Morphology of adult human pancreas exocrine cells during in-vitro adhesion culture.
b Cultured exocrine cells obtained during human islet isolation. c Glucagon expression in adhesion exocrine cell culture. d CK19 expression in
exocrine cells. CK19 plus SSEA-4 staining is also shown. e SSEA-4 expression in exocrine cells. SSEA-4 plus CK19 expression is also shown.
f Coexpression of SSEA-4 and CK19. g Amylase expression in exocrine cells. Amylase plus SSEA-4 staining is also shown. h SSEA-4 plus amylase
expression. i Coexpression of amylase and SSEA-4 in exocrine cells. Scale bars: 100 μm. AMY amylase, CK19 cytokeratin 19, GLU glucagon, INS
insulin, SSEA-4 stage-specific embryonic antigen 4
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cells were present in a portion of pancreatic duct cells,
pure separated SSEA-4+ cells exhibited characteristics
similar to those of ES cells, whereas CA19-9+ cells
did not.
SSEA-4+ cells differentiated in vivo into adult human
pancreatic duct cells
In this experiment, we could not identify any specific
methods for long-term in-vitro culture of pure separated
SSEA-4+ cells. Therefore, we transplanted pure sepa-
rated cells into the dorsal subcutaneous region of mice
in order to compare the in-vivo ability of the two cell
types to differentiate (Fig. 5a). The transplanted pancre-
atic duct cells (CA19-9+ cells) showed few organized
pancreatic intralobular ducts (PIDs; Fig. 5b), which
consisted of a lumen and cuboidal epithelium surround-
ing the lumen (Fig. 5b′). However, no epithelial-like cells
were detected in the area of the transplanted CA19-9–
cells (Fig. 5c), and we could not identify the transplanted
cells in the dermis area of the mouse skin (Fig. 5c′).
Interestingly, a number of PIDs were observed in trans-
planted areas of SSEA-4+ cells (Fig. 5d). Lumens of vari-
ous dimensions and cuboidal epithelium were observed
in PIDs formed from SSEA-4+ cells in vivo (Fig. 5d′).
In transplanted SSEA-4– cells, no histological changes
were observed, similar to the results of CA19-9– cells
(Fig. 5e, e′). Next, we confirmed by immunofluores-
cence staining whether these newly formed PIDs were
pancreatic ducts. In transplanted CA19-9+ cells, although
few PIDs were formed, CA19-9 was expressed throughout
Fig. 2 Distribution of SSEA-4-expressing cells in adult human pancreatic exocrine cells. a CA19-9 expression in cultured exocrine cells (68.21 ±
6.57 %). b Amylase expression in cultured exocrine cells (12.22 ± 5.18 %) c Distribution of total cultured exocrine cells plotted according to cell size
(common cell size: P2; small cell size: P3). d Negative isotype controls were analyzed using PE-conjugated IgG and FITC-conjugated IgG. e Distributions
of SSEA-4 expressing cells in exocrine cells (Q1: 21.57 ± 3.17 %). f Correlation analysis of CA19-9 and SSEA-4 expression in exocrine cells: SSEA-4+ cells
(Q1: 3.02 ± 1.73 %), SSEA-4+/CA19-9+ cells (Q2: 9.65 ± 2.68 %), SSEA-4–/CA19-9– cells (Q3: 10.92 ± 2.47 %), and SSEA-4–/CA19-9+ cells (Q4: 71.35 ± 11.58 %).
g Correlation analysis of amylase and SSEA-4 expression in exocrine cells in common cell size gating: SSEA-4+ cells (Q1: 18.20 ± 3.12 %), SSEA-4+/amylase-
positive cells (Q2: 1.07 ± 0.58 %), SSEA-4–/amylase-negative cells (Q3: 80.85 ± 6.56 %), and SSEA-4–/amylase-positive cells (Q4: 10.75 ± 4.235). h Negative
isotype controls in small cell size gating. i Distribution of SSEA-4-expressing cells (Q1: 12.44 ± 3.45 %). j Correlation analysis of CA19-9 and SSEA-4
expression in small-sized exocrine cells: SSEA-4+ cells (Q1: 1.97 ± 0.82 %), SSEA-4+/CA19-9+ cells (Q2: 7.72 ± 0.86 %), SSEA-4–/CA19-9– cells (Q3:
66.20 ± 7.84 %), and SSEA-4–/CA19-9+ cells (Q4: 23.17 ± 25.76 %). k Correlation analysis of amylase and SSEA-4 expression in small cell size gating:
SSEA-4+ cells (Q1: 7.32 ± 0.83 %), SSEA-4+/amylase-positive cells (Q2: 0.67 ± 0.36 %), SSEA-4–/amylase-negative cells (Q3: 90.07 ± 4.22 %), and SSEA-4–/
amylase-positive cells (Q4: 5.12 % ± 2.59 %). IgG-PE phycoerythrin, SSEA-4 stage-specific embryonic antigen 4
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the PIDs (Fig. 5f, f′). Similarly, CA19-9 expression was
detected in all newly formed PIDs from SSEA-4+ cells
(Fig. 5g, g′). The areas of CA19-9-expressing pancreatic
duct cells relative to the total transplanted area were
41.02 ± 17.55 % in SSEA-4+ cells and 7.50 ± 4.70 % in
CA19-9+ cells (Fig. 5h).
In-vivo differentiated pancreatic duct cells derived from
SSEA-4+ cells expressed Sox9 and Ngn3
To identify the specific genes associated with pancreas
differentiation, newly formed PIDs from SSEA-4+ cells,
CA19-9+ cells, or normal adult human pancreatic ducts
were evaluated using immunofluorescence staining. Hu-
man adult pancreatic ducts, which consisted of pancre-
atic main ducts (PMDs) and PIDs, excluding acinar cells
and islets, were isolated from pancreatic tissue in order
to analyze control cell morphology and gene expression
profiles (Additional file 2: Figure S1a). Pancreatic duct
cells and morphology were detected without acinar
cells and islets in H&E slide sections of both PMDs
and PIDs (Additional file 2: Figure S1b, c). Many
small duct cells, including the lumen, were detected
in PMD tissues, similar to those in PIDs from SSEA-4+
cells (Additional file 2: Figure S1b′); however, long
extended ducts were detected in PID tissues (Additional
file 2: Figure S1c′). To identify specific gene expression
patterns associated with pancreas differentiation in pan-
creatic duct cells, the expression of the major transcrip-
tion factor Sox9, which is associated with pancreatic
development, and Ngn3, a key transcription factor in-
volved in endocrine cell development, was confirmed by
immunofluorescence staining. Sox9 expression was spe-
cifically detected in the nuclei of PIDs from SSEA-4+
cells (Fig. 6a) and normal pancreatic duct tissue (Additional
file 2: Figure S1d) but was weakly expressed in PIDs from
CA19-9+ cells (Fig. 6b).
The percentage of Sox9-expressing cells in total PIDs
was considerably higher in PIDs from SSEA-4+ cells
than in PIDs from CA19-9+ cells (81.54 ± 5.22 % versus
21.96 ± 2.7 %, respectively; Fig. 6c). The expression of
Ngn3 in nuclei of PIDs was detected in PIDs from
SSEA-4+ cells and PIDs from CA19-9+ cells; however,
staining was observed in nearly all PIDs from SSEA-4+
cells (Fig. 6d) but only in few PIDs from CA19-9+ cells
Fig. 3 Suspension cultures of adult human pancreas exocrine cells and separation for collection of pure SSEA-4+ cells. a Processes used for
collection of pure single cells. Isolated crude exocrine cells from human partial pancreas tissues formed spheres during suspension culture.
Exocrine cell spheres were separated into single cells by TE, and specific positive/negative cells were selected by MACS. b Spherical morphology
of exocrine cells during suspension culture. c CA19-9 expression in spherical exocrine cells. b SSEA-4 expression in spherical exocrine cells. e Insulin
expression in spherical exocrine cells. f SSEA-4 expression in cultured SSEA-4+ and SSEA-4– cells. g CA19-9 expression in cultured CA19-9+ and CA19-9–
cells. h Viability of selected pure single SSEA-4+ cells or CA19-9+ cells during culture. Scale bars: 100 μm. Ab antibody, MACS magnetic-activated cell
sorting, SSEA-4 stage-specific embryonic antigen 4
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(Fig. 6e). Ngn3 expression was also highly detected in nor-
mal pancreatic duct tissue (Additional file 2: Figure S1e).
The percentage of cells expressing Ngn3 of the total PID
cells was higher in PIDs from SSEA-4+ cells than in PIDs
from CA19-9+ cells (70.99 ± 5.17 % versus 19.98 ± 2.54 %;
Fig. 6f). However, Pdx1, a major transcription factor
involved in pancreatic development, was not detected in
PIDs from SSEA-4+ cells (Fig. 6g) or in PIDs from CA19-
9+ cells (Fig. 6h). Similarly, Pdx1 expression was not
observed in adult pancreatic duct tissue (Additional file 2:
Figure S1f). We confirmed proliferation of newly formed
PIDs by immunostaining with Ki-67, a proliferation
marker, to determine whether these cells exhibited pro-
liferative activity similar to ES cells; however, Ki-67-
expressing cells were not detected in PIDs from SSEA-4+
cells (Fig. 6i) or in PIDs from CA19-9+ cells (Fig. 6j),
and few Ki-67 cells were detected in adult PID tissues
(Additional file 2: Figure S1g). Finally, we confirmed
the expression of clusterin, a pancreatic differentiation
marker, in PIDs and detected high expression of this
marker in peripheral PIDs derived from SSEA-4+ cells
(Fig. 6k, l).
Discussion
In this study, we evaluated the characteristics and fea-
tures of ES-like cells expressing SSEA-4 in the adult
human pancreas. To confirm the characteristics of cells
expressing SSEA-4, we compared the cells with cells
costained with Ck19 or amylase. Immunostaining
showed that CA19-9+ cells were detected in around cell
clusters, and that amylase-positive cells were present
within the cell clusters. SSEA-4+ cells were found at the
edges of cell clusters. Although some cells coexpressed
SSEA-4 and CA19-9 or amylase, these findings were not
reliable for quantitative analysis (Additional file 3: Figure
S2b–g). However, FACS analysis showed that 9.65 ± 2.68 %
of normal-sized cells coexpressed SSEA-4 and CA19-9,
whereas 7.72 ± 0.86 % of small-sized cells coexpressed
these targets. In addition, CK19 was specifically expressed
in CA19-9+ cells, whereas amylase was not; amylase
was only expressed in the CA19-9-negative population
(Additional file 3: Figure S2a). Although weak CK19
expression was detected in CA19-9-negative cells, this
expression was thought to be due to the terminal duct
cells connected with exocrine cells directly. Overall, the
Fig. 4 Relative expression of key transcription factors as markers of ES cells. a Oct4, Nanog, Klf4, Sox2, and c-Myc expression in crude exocrine cells
on days 2, 4, 6, and 8 of culture by conventional PCR. b Expression levels of Oct4, Nanog, Klf4, Sox2, and c-Myc in CA19-9+ and CA19-9– cells by
qPCR. c Relative expression of Oct4, Nanog, Klf4, Sox2, and c-Myc in SSEA-4+ and SSEA-4– cells by qPCR. d Expression of Oct4, Nanog, Klf4, Sox2,
and c-Myc in SSEA-4+ and CA19-9+ cells by qPCR. d days, SSEA-4 stage-specific embryonic antigen 4
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expression of SSEA-4 was greater in CA19-9+ cells than
CA19-9– cells. Although SSEA-4 expression has been
found in dividing CA19-9+ and CA19-9– cells, the cells
expressing SSEA-4 seemed to be distributed in the duct
cells. However, when using the anti-SSEA-4 antibody to
separate the cells, only cells expressing SSEA-4 were more
effectively purified than when using anti-CA19-9 anti-
bodies. These results were intriguing because almost all
SSEA-4+ cells were present in pancreatic ducts, which are
known to contain stem/progenitor cells and multipotent
stem cells [17, 18]. Notably, the distribution of SSEA-4+
cells was not associated with cell size.
Moreover, SSEA-4+ cells expressed ES cell-specific
transcription factors, with higher expression levels than
those in pancreatic duct cells expressing CA19-9, sug-
gesting that SSEA-4+ cells in the adult human pancreas
may exhibit gene expression patterns similar to those of
ES cells. However, SSEA-4+ cells did not exhibit rapid
proliferation rates and self-renewal ability, and the via-
bility of SSEA-4+ cells was gradually decreased in vitro
under single-cell culture conditions. Finally, in-vitro pas-
sage culture of epithelial-like primary pancreas exocrine
cells was not possible; however, mesenchymal-like stem
cells contained in the crude exocrine cells were able to
be passaged continually (data not shown). Our data
provided important insights into the characteristics of
SSEA-4+ cells in pancreatic ducts.
Although we have not determined specific in-vitro
culture conditions for continuous growth of SSEA-4+
single cells, we did show that isolated SSEA-4+ single
cells could differentiate into PIDs in vivo after trans-
plantation into the dorsal subcutaneous region of mice.
In this study, we focused on the differentiation capacity
and regenerating activity of cells expressing SSEA-4 and
Fig. 5 In-vivo differentiation of SSEA-4+ cells. a Selected pure CA19-9+, CA19-9–, SSEA-4+, or SSEA-4– cells were transplanted into mice and then
harvested 5 weeks after transplantation. b Morphology of newly formed pancreatic ducts in tissues derived from CA19-9+ cells. b′ Magnified
image from b. Lu lumen. c Dermis of the dorsal skin of mice in tissues derived from CA19-9– cells. c′ Magnified image from c. d Morphology of
newly formed pancreatic ducts in tissues derived from SSEA-4+ cells. d′ Magnified image from d. e Morphology of tissues derived from mice
inoculated with SSEA-4– cells. e′ Magnified image from e. f CA19-9 staining in tissue of CA19-9+ cells. f′ Magnified image from f. CA19-9-expressing
cells in small undifferentiated-like pancreatic ductal cells. g CA19-9 staining in tissues of SSEA-4+ cells. g′ CA19-9-expressing cells in
actively differentiating pancreatic ductal cells. h Area of newly formed pancreatic ductal cells in total tissue area for SSEA-4+ cells and
CA19-9+ cells. Scale bars: b–g, 50 μm; b′–e′, 20 μm; f′ and g′, 10 μm. SSEA-4 stage-specific embryonic antigen 4
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found newly formed PID structures within the area of
transplanted SSEA-4+ cells. Although few newly formed
PIDs were detected in areas of transplanted CA19-9+
cells, these PIDs formed in smaller areas than those in
the group transplanted with SSEA-4+ cells and showed
lower expression of Sox9 and Ngn3. These results dem-
onstrated that there were few cells expressing SSEA-4+
in the transplanted population of CA19-9+ cells, and
that there were not sufficient numbers of cells to induce
differentiation and regeneration. Specifically, it was diffi-
cult to determine whether the transplanted CA19-9+
cells simply proliferated in vivo because the cell
populations, including CA19-9+ cells, showed almost no
proliferation during both in-vitro culture and after trans-
plantation in vivo.
SSEA-4– and CA19-9– cells also did not differentiate
to PIDs in vivo because SSEA-4+ cells were not present
in these cell populations. Although a small number of
cells expressed SSEA-4 presence in CA19-9– cell popu-
lations, these cells were mixed with a number of exo-
crine cells expressing amylase. Therefore, we concluded
that SSEA-4– or CA19-9– cells may not differentiate into
PIDs due to impurities and the presence of a small num-
ber of cells expressing SSEA-4 in vivo.
Fig. 6 Expression of Sox9 and Ngn3 in newly formed pancreatic ductal cells. a Sox9 expression in the nuclei of newly formed pancreas ductal
cells from tissues derived from SSEA-4+ cells. Scale bars: left panel, 50 μm; right panel, 10 μm. b Sox9 expression in newly formed pancreas ductal
cells from tissues derived from CA19-9+ cells. Scale bars: left panel, 50 μm; right panel, 10 μm. c Percentage of Sox9+ cells in total pancreatic
ductal cells from tissues derived from SSEA-4+ or CA19-9+ cells. **P = 0.0005. d Ngn3 expression in tissues derived from SSEA-4+ cells. Scale bars:
left panel, 50 μm; right panel, 10 μm. e Ngn3 expression in tissues derived from CA19-9+ cells. Scale bars: left panel, 50 μm; right panel, 10 μm.
f Percentage of Ngn3+ cells in total pancreatic ductal cells in tissues derived from SSEA-4+ or CA19-9+ cells. g Pdx1 expression in tissues derived
from SSEA-4+ cells. h Pdx1 expression in tissues derived from CA19-9+ cells. i Ki-67 expression in newly formed pancreatic ductal cells from
tissues derived from SSEA-4+ cells. j Ki-67 expression in newly formed pancreatic ductal cells from tissues derived from CA19-9+ cells. k Clusterin
expression in newly formed pancreatic ductal cells from tissues derived from SSEA-4+ cells. l Clusterin expression in newly formed pancreatic
ductal cells from tissues derived from CA19-9+ cells. Scale bars: g–l, 50 μm. SSEA-4 stage-specific embryonic antigen 4
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Newly formed pancreatic ducts are distinctly detected
during regeneration of the pancreas after mechanical in-
jury using partial pancreatectomy (pPx) [19, 20] or duct
ligation [21, 22] in rodents. Furthermore, these ducts
directly differentiate into exocrine cells, such as acinar
cells, or into endocrine cells (e.g., insulin-producing
cells) [23, 24]. For these reasons, many studies have re-
ported that multipotent stem cells/progenitor cells,
which may able to induce the differentiation/regener-
ation of the pancreas, are present in pancreatic ducts
and newly formed ducts [25–27]. In this study, we found
that these newly formed pancreatic ducts expressed
Sox9, which is involved in progenitor proliferation and
differentiation in both developmental systems [28–30]
and plays a role in pancreatic development, including
islet development [30, 31]. We confirmed the expression
of CA19-9 in newly formed PIDs by immunofluores-
cence staining. All newly formed PIDs in the total trans-
plantation area were stained with CA19-9, and Sox9 and
Ngn3 were also detected in the nuclei of cells constitut-
ing the newly formed PIDs. Therefore, the percentages
of cells expressing Sox9 and Ngn3 were calculated rela-
tive to the total number of PIDs. Notably, Sox9 was
expressed throughout the PMDs and PIDs, and newly
formed PIDs from SSEA-4+ cells showed a Sox9 expres-
sion pattern in vivo similar to that of the adult pancre-
atic duct. Thus, these data demonstrated that isolated
SSEA-4+ cells from the adult human pancreas may be
able to differentiate into functional pancreatic ducts ex-
pressing Sox9 in vivo, similar to adult pancreatic ducts.
Ngn3, which is associated with the development and
differentiation of the pancreas, was also detected in adult
pancreatic ducts and newly formed PIDs from SSEA-4+
cells. Ngn3 is a marker of endocrine progenitors [32, 33]
and neogenesis [34, 35] in the adult pancreas. Addition-
ally, Pdx1-expressing cells were confirmed in newly
formed PIDs because Pdx1 is a critical transcription fac-
tor in the embryologic development [36, 37] and regen-
eration of the pancreas [38]. However, Pdx1 was not
detected in PIDs derived from SSEA-4+ cells or CA19-9
+ cells or in adult pancreatic ducts.
In our study, no proliferative cells were detected in
newly formed PIDs in vivo, regardless of the cell
phenotype. These data indicated that although SSEA-
4+ cells may have gene expression patterns similar to
those of ES cells, proliferation activity may be sup-
pressed because the tissues are adult tissues. Clusterin
is glycoprotein that induces neogenic ductule and islet
formation during regeneration of the pancreas after
injury, such as pPX. Clusterin is usually expressed
strongly in regenerating ductal cells and developing
acinar cells. In this study, clusterin was generally
expressed in only newly formed PIDs from SSEA-4+
cells. Therefore, although newly formed PIDs were
observed in the transplanted areas of CA19-9+ cells
and SSEA-4+ cells, newly formed PIDs all contained
SSEA-4+ cells, suggesting the occurrence of regener-
ation and differentiation. In this study, we confirmed
that SSEA-4+ cells may differentiate into pancreatic
ducts during the early developmental stage of pan-
creas formation, and we expected that SSEA-4+ cells
may differentiate into endocrine cells, including
insulin-producing β cells. However, insulin-expressing
cells were not detected in PIDs derived from either
cell type (data not shown). This may be because the
transplantation area did not have appropriate environ-
mental factors for differentiation into endocrine cells.
Therefore, further studies are needed to achieve
transplantation into the appropriate location, such as
the pancreas, in order to observed differentiation of
SSEA-4+ cells into β cells.
Conclusions
Our data indicated that SSEA-4+ cells in the adult
human pancreas may exhibit transcription factor
expression patterns similar to those of ES cells and
therefore were able to differentiate in vivo into devel-
oping pancreatic duct cells expressing Sox9 and
Ngn3. These data suggested that isolated SSEA-4+
cells derived from the adult human pancreas may
have applications as pancreatic stem/progenitor cells
for differentiation and regeneration of the adult
pancreas. In addition, these SSEA-4+ cells may have
practical uses in the differentiation/regeneration of
insulin-producing cells. Further studies are needed to in-
vestigate these possibilities.
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Additional file 1 is Table S1 presenting PCR primer sequences. a Gene-
specific primers for reverse-transcription-PCR. b Gene-specific primers for
qPCR. (TIF 89 kb)
Additional file 2 is Figure S1 showing morphology of adult human
pancreatic ducts. a Adult human pancreatic ducts were isolated from
partial pancreatic tissue using a dissecting microscope. Tissues were
divided into PMDs and PIDs. b Morphologies of PMDs. b′ Magnified
image from b. c Long outstretched duct structures in PIDs. c′ Magnified
image from c. d Sox9-positive cells in the nucleolus of pancreatic ductal
cells. e Ngn3 expression in ductal cells. f Pdx1 was not detected in adult
pancreatic ductal cells. g Ki-67 staining for detection of proliferation in
pancreatic ductal cells. (TIF 852 kb)
Additional file 3 is Figure S2 showing identification of cells expressing
SSEA-4. a Identity of separated cell populations was confirmed by PCR.
Cells expressing SSEA-4 were detected in both CA19-9+ cell populations
and SSEA-4+ cell populations. However, cytokeratin 19 and amylase were
detected in SSEA-4+ cell populations. b SSEA-4 staining was detected in
exocrine cells. c Cytokeratin 19 was stained in exocrine cells. d Merged
image of SSEA-4 staining and CK19 staining. Arrows in b–d indicate
SSEA-4 and CK19 coexpressing cells. e SSEA-4 staining was detected in
exocrine cells. f Amylase-expressing exocrine cells. g Merged image of
SSEA-4 staining and amylase staining. Arrows in e–g indicate SSEA-4 and
amylase coexpressing cells. (TIF 647 kb)
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